126 related articles for article (PubMed ID: 8900604)
21. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
[TBL] [Abstract][Full Text] [Related]
22. Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis.
Garbe C; Drechsler S; Fiedler H; Tilgen W; Landthaler M; Schroeder K; Kuehne KH; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):12-6. PubMed ID: 9113121
[TBL] [Abstract][Full Text] [Related]
23. Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis? The French Navoban Study Group.
Marty M; Kleisbauer JP; Fournel P; Vergnenegre A; Carles P; Loria-Kanza Y; Simonetta C; de Bruijn KM
Anticancer Drugs; 1995 Feb; 6 Suppl 1():15-21. PubMed ID: 7749165
[TBL] [Abstract][Full Text] [Related]
24. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
[TBL] [Abstract][Full Text] [Related]
25. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
[TBL] [Abstract][Full Text] [Related]
26. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
27. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
[TBL] [Abstract][Full Text] [Related]
28. Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting.
Van Belle SJ; Stamatakis L; Bleiberg H; Cocquyt VF; Michel J; de Bruijn KM
Ann Oncol; 1994 Nov; 5(9):821-5. PubMed ID: 7848884
[TBL] [Abstract][Full Text] [Related]
29. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
[TBL] [Abstract][Full Text] [Related]
30. [Ondansetron (GR 38032F), a competitive 5-HT3 receptor antagonist as an antiemetic in cytostatic drug-induced nausea and vomiting. An open, substance-oriented phase II/III study].
Serve H; Perker M; Ertl A; Reichold M; Fink U; Berdel WE
Onkologie; 1990 Oct; 13(5):369-74. PubMed ID: 2150552
[TBL] [Abstract][Full Text] [Related]
31. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy.
Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
Med Pediatr Oncol; 1995 Dec; 25(6):457-62. PubMed ID: 7565308
[TBL] [Abstract][Full Text] [Related]
32. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.
Sorbe B
Ann Oncol; 1993; 4 Suppl 3():39-42. PubMed ID: 8363999
[TBL] [Abstract][Full Text] [Related]
33. Prevention of emesis by ICS 205-930 in children receiving cytotoxic chemotherapy.
Hachimi-Idrissi S; De Schepper J; Maurus R; Otten J
Eur J Cancer; 1993; 29A(6):854-6. PubMed ID: 8484976
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis.
Harman GS; Omura GA; Ryan K; Hainsworth JD; Cramer MB; Hahne WF
Cancer Chemother Pharmacol; 1996; 38(4):323-8. PubMed ID: 8674154
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of the oral neurokinin-1 receptor antagonist aprepitant for nausea and vomiting induced by cisplatin and carboplatin in Japanese patients with gynecological cancer.
Ikeda M; Shida M; Hirasawa T; Muramatsu T; Mikami M
J Obstet Gynaecol Res; 2017 Oct; 43(10):1613-1620. PubMed ID: 28691209
[TBL] [Abstract][Full Text] [Related]
36. [Antiemetic treatment and chemotherapy: general review].
Lecomte S; Adenis A; Bonneterre J
Rev Med Interne; 1994; 15(11):752-69. PubMed ID: 7846392
[TBL] [Abstract][Full Text] [Related]
37. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
[TBL] [Abstract][Full Text] [Related]
39. The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting.
Watters J; Riley M; Pedley I; Whitehead A; Overend M; Goss I; Allgar V
Clin Oncol (R Coll Radiol); 2001; 13(6):422-6. PubMed ID: 11824878
[TBL] [Abstract][Full Text] [Related]
40. Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings.
Hickok JT; Roscoe JA; Morrow GR; Stern RM; Yang B; Flynn PJ; Hynes HE; Kirshner JJ; Rosenbluth RJ
Cancer; 1999 Jul; 86(1):64-71. PubMed ID: 10391565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]